Published in Int J Radiat Oncol Biol Phys on October 01, 1998
Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. Radiother Oncol (2011) 1.14
Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal. J Med Phys (2006) 0.97
The impact of linac output variations on dose distributions in helical tomotherapy. Phys Med Biol (2007) 0.93
Mathematical Formulation of DMH-Based Inverse Optimization. Front Oncol (2014) 0.76
Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma. Front Oncol (2017) 0.75
A technique for the quantitative evaluation of dose distributions. Med Phys (1998) 7.49
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys (1999) 6.16
Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys (1994) 4.13
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys (1998) 2.97
Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys (1999) 2.95
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys (2001) 2.85
The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1980) 2.64
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med (1990) 2.64
MicroRT-small animal conformal irradiator. Med Phys (2007) 2.46
External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys (1990) 2.29
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA (1999) 2.16
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15
Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys (2001) 2.14
Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (1992) 2.03
Effect of rest interval on tumor and normal tissue response--a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502) Int J Radiat Oncol Biol Phys (1993) 1.96
Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys (1995) 1.88
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. Int J Radiat Oncol Biol Phys (1991) 1.88
N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.77
Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys (1993) 1.74
AAPM code of practice for radiotherapy accelerators: report of AAPM Radiation Therapy Task Group No. 45. Med Phys (1994) 1.70
Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys (1992) 1.67
Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys (1990) 1.64
Clinical electron-beam dosimetry: report of AAPM Radiation Therapy Committee Task Group No. 25. Med Phys (1991) 1.60
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope (2001) 1.59
Secondary malignancy among seminoma patients treated with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (1995) 1.55
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys (2000) 1.54
Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys (1990) 1.52
Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol (2001) 1.51
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys (1991) 1.50
Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.50
Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer (1984) 1.47
Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys (1999) 1.46
Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys (1993) 1.45
A volumetric study of measurements and calculations of lung density corrections for 6 and 18 MV photons. Int J Radiat Oncol Biol Phys (1997) 1.44
Radiotherapy (2500 rad) for testicular leukemia: local control and subsequent clinical events: a Southwest Oncology Group study. Cancer (1980) 1.42
Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol (1994) 1.41
Estimation of tissue volume irradiated by intracavitary implants. Int J Radiat Oncol Biol Phys (1993) 1.40
Radiation therapy for stage I and IIA testicular seminoma. Int J Radiat Oncol Biol Phys (1994) 1.38
Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys (2001) 1.37
Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol Immunol (1999) 1.33
Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys (1998) 1.29
Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys (1987) 1.28
Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys (1992) 1.28
Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int J Cancer (2000) 1.23
Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence. Cancer (1983) 1.21
Hemilaryngectomy following radiation failure for carcinoma of the vocal cords. Laryngoscope (1970) 1.20
Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys (1999) 1.19
Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys (1986) 1.17
Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer (2001) 1.15
Anaplastic transformation in verrucous carcinoma of the oral cavity after radiation therapy. Radiology (1966) 1.15
Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (1996) 1.14
Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int J Radiat Oncol Biol Phys (1990) 1.13
Cervical lymph node metastasis: unknown primary cancer. Cancer (1973) 1.13
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer. Br J Radiol (2010) 1.12
Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer (1982) 1.10
Cervical tumor control evaluated with ICRU 38 reference volumes and integrated reference air kerma. Radiother Oncol (2001) 1.09
Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys (2001) 1.08
Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperthermia (1999) 1.08
Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys (1989) 1.07
A software tool for the quantitative evaluation of 3D dose calculation algorithms. Med Phys (1998) 1.05
The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int J Radiat Oncol Biol Phys (1992) 1.03
Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma. Cancer (1980) 1.02
Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer (1977) 1.01
Characterization of a commercial multileaf collimator used for intensity modulated radiation therapy. Med Phys (2001) 0.99
Carcinoma of the fallopian tube. Management and sites of failure. Cancer (1986) 0.99
Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys (2001) 0.99
Femoral neck fracture following groin irradiation. Int J Radiat Oncol Biol Phys (1995) 0.98
Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg (1999) 0.98
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. J Clin Oncol (1984) 0.98
Quantitative dosimetric verification of an IMRT planning and delivery system. Radiother Oncol (1998) 0.98
Radiation induced lumbosacral plexopathy in gynecologic tumors: clinical findings and dosimetric analysis. Int J Radiat Oncol Biol Phys (1993) 0.97
Pitfalls in the use of death certificates for assessing cause of death: a study of tonsil carcinoma patients. Am J Clin Oncol (1984) 0.97
Radiation therapy in the management of carcinoma of the prostate. Curr Probl Cancer (1976) 0.97
Objective evaluation of 3-D radiation treatment plans: a decision-analytic tool incorporating treatment preferences of radiation oncologists. Int J Radiat Oncol Biol Phys (1993) 0.96
Validation of a precision radiochromic film dosimetry system for quantitative two-dimensional imaging of acute exposure dose distributions. Med Phys (2000) 0.96
Management of pathologic fractures. Cancer (1972) 0.96
Radiation therapy in the treatment of chemodectomas. Laryngoscope (1987) 0.95
Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys (2001) 0.95